Glenmark is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India

Jan 03, 2024

Mumbai (Maharashtra) [India], January 3: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical company, has launched a biosimilar of the popular 10,11 anti-diabetic drug,...